Zhuo-Zhi Liang
Overview
Explore the profile of Zhuo-Zhi Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ye H, Tang L, Liang Z, Chen Q, Li Y, Liu Q, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Sep;
31(11):2030-2037.
PMID: 36084325
Background: Previous studies have found that acute febrile infection may decrease the risk of breast cancer. Meanwhile, it is well known that interleukin-6 (IL6) played dual roles in the tumor...
2.
Zhang Y, Liang Z, Li Y, Lin Y, Liu Q, Xie X, et al.
Breast Cancer Res Treat
. 2022 Apr;
193(3):677-684.
PMID: 35435529
Purpose: Results of the associations between weight change after breast cancer diagnosis and prognosis were inconsistent. The modification effects of menopausal status and endocrine therapy on the associations remain poorly...
3.
Liang Z, Zhang Y, Zhu R, Li Y, Jiang H, Li R, et al.
Environ Sci Pollut Res Int
. 2021 Nov;
29(15):22056-22068.
PMID: 34773240
The antagonistic effect of selenium (Se) against cadmium (Cd)-induced breast carcinogenesis was reported, but underlying mechanisms were unclear. The aim of this study was to identify the epigenetically regulated genes...
4.
Zhou M, Chen Q, Yang Y, Liang Z, Li Y, Huang Z, et al.
Virchows Arch
. 2021 Sep;
480(2):259-267.
PMID: 34562173
Glutaminase 1 (GLS) is a therapeutic target for breast cancer; although GLS inhibitors have been developed, only a few subjects responded well to the therapy. Considering that the expression of...
5.
Chen Q, Yang Y, Liang Z, Chen J, Li Y, Huang Z, et al.
Breast Cancer Res Treat
. 2021 Feb;
187(3):867-875.
PMID: 33604715
Purpose: Results of previous studies on the associations between Forkhead box A1 (FOXA1) expression in breast cancer tissues and the prognosis varied depending on the follow-up durations. The present study...
6.
Liang Z, Zhu R, Li Y, Jiang H, Li R, Wang Q, et al.
J Trace Elem Med Biol
. 2020 Nov;
64:126677.
PMID: 33246299
Objectives: Selenium (Se) was a potential anticancer micronutrient with proposed epigenetic effect. However, the Se-induced epigenome in breast cancer cells was yet to be studied. Methods: The profiles of DNA...
7.
Liang Z, Zhu R, Li Y, Jiang H, Li R, Tang L, et al.
Chemosphere
. 2020 Oct;
261:128148.
PMID: 33113665
Cadmium (Cd) has been confirmed to be associated with breast carcinogenesis, but the mechanism was not clarified yet. Given that epigenetic modification was speculated as underlying mechanism, we examined the...
8.
Zhang J, Wang M, Wang X, Li Y, Liang Z, Lin Y, et al.
Cancer Med
. 2019 Nov;
9(1):385-393.
PMID: 31724329
Reproductive factors associated with breast cancer risk may also affect the prognosis. This study aimed to evaluate the associations of multiple reproductive factors with breast cancer prognosis and the modifying...
9.
Liang Z, Zhang Y, Lin Y, Liu Q, Xie X, Tang L, et al.
Sleep Med
. 2018 Dec;
54:153-158.
PMID: 30580187
Objectives: Sleep has been closely linked to breast cancer risk. However, the association between sleep and breast cancer prognosis remains unclear. The aim of this study was to evaluate the...